Setting

Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248427 | Pages: 139

Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country. Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • CRO for Pre-clinical Development • CRO for Phase I Trials • CRO for Phase II Trials • CRO for Phase III Trials • CRO for Phase IV Trials • Laboratory Services • Consulting Services • Data Management Services Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Infectious Diseases • Oncology • Metabolic Disorders • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Gastrointestinal Disorders • Other Therapeutic Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Pharmaceutical & Biopharmaceutical Companies • Medical Device Companies • Academic Institutes Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories CMIC Co. Ltd Covance Inc. Hangzhou Tigermed Consulting Co., Ltd. ICON Plc IQVIA Holdings Inc. LSK Asia Pacific Pharma Service Co., Ltd. Novotech Pty Ltd PAREXEL International Corporation Pharmaceutical Product Development LLC (PPD) PRA Health Sciences Inc. Quanticate Ltd Samsung Bioepis Co., Ltd. SGS SA (SGS Life Sciences) Syneos Health Inc. WuXi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	33
2.4 Emerging Opportunities and Market Trends	36
2.5 Porter’s Fiver Forces Analysis	40
3 Segmentation of Asia Pacific Market by Service	44
3.1 Market Overview by Service	44
3.2 CRO for Pre-clinical Development	46
3.3 CRO for Phase I Trials	47
3.4 CRO for Phase II Trials	48
3.5 CRO for Phase III Trials	49
3.6 CRO for Phase IV Trials	50
3.7 Laboratory Services	51
3.8 Consulting Services	52
3.9 Data Management Services	53
4 Segmentation of Asia Pacific Market by Therapeutic Application	54
4.1 Market Overview by Therapeutic Application	54
4.2 Infectious Diseases	56
4.3 Oncology	57
4.4 Metabolic Disorders	58
4.5 Cardiovascular Disorders	59
4.6 Central Nervous System	60
4.7 Respiratory Disorders	61
4.8 Gastrointestinal Disorders	62
4.9 Other Therapeutic Applications	63
5 Segmentation of Asia Pacific Market by End User	64
5.1 Market Overview by End User	64
5.2 Pharmaceutical & Biopharmaceutical Companies	66
5.3 Medical Device Companies	67
5.4 Academic Institutes	68
6 Asia-Pacific Market 2019-2030 by Country	69
6.1 Overview of Asia-Pacific Market	69
6.2 Japan	72
6.3 China	75
6.4 Australia	77
6.5 India	79
6.6 South Korea	82
6.7 Rest of APAC Region	84
7 Competitive Landscape	86
7.1 Overview of Key Vendors	86
7.2 New Product Launch, Partnership, Investment, and M&A	90
7.3 Company Profiles	91
Charles River Laboratories	91
CMIC Co. Ltd	93
Covance Inc.	95
Hangzhou Tigermed Consulting Co., Ltd.	99
ICON Plc	102
IQVIA Holdings Inc.	105
LSK Global Pharma Service Co., Ltd.	109
Novotech Pty Ltd	111
PAREXEL International Corporation	113
Pharmaceutical Product Development LLC (PPD)	117
PRA Health Sciences Inc.	119
Quanticate Ltd	121
Samsung Bioepis Co., Ltd.	123
SGS SA (SGS Life Sciences)	125
Syneos Health Inc.	128
WuXi AppTec Inc.	131
8 Investing in Asia Pacific Market: Risk Assessment and Management	133
8.1 Risk Evaluation of Asia Pacific Market	133
8.2 Critical Success Factors (CSFs)	136
Related Reports and Products	139
List Of Tables:


Table 1.  Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn	27
Table 4. Worldwide Total Number of Registered Clinical Trials	29
Table 5. World Health Spending by Region, $ bn, 2013-2020	32
Table 6.  Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market	36
Table 7. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn	44
Table 8. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	54
Table 9. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn	64
Table 10. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn	70
Table 11. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn	74
Table 12. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	74
Table 13. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn	74
Table 14. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn	76
Table 15. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	76
Table 16. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn	76
Table 17. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn	78
Table 18. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	78
Table 19. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn	78
Table 20. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn	81
Table 21. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	81
Table 22. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn	81
Table 23. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn	83
Table 24. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	83
Table 25. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn	83
Table 26. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn	85
Table 27. Breakdown of World Market by Key Vendor, 2020, %	88
Table 28. Charles River Laboratories: Company Snapshot	91
Table 29. Charles River Laboratories: Product Portfolio	92
Table 30. CMIC Co. Ltd.: Company Snapshot	93
Table 31. CMIC Co. Ltd.: Business Segmentation	94
Table 32. CMIC Co. Ltd.: Revenue by Region, 2018, %	94
Table 33. Covance Inc.: Company Snapshot	95
Table 34. Covance Inc.: Product Portfolio	96
Table 35. Covance Inc.: Revenue by Region, 2020, %	97
Table 36. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot	99
Table 37. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation	100
Table 38. ICON Plc: Company Snapshot	102
Table 39. ICON Plc: Business Segmentation	102
Table 40. ICON Plc: Product Portfolio	103
Table 41. ICON Plc: Revenue by Region, 2020, %	103
Table 42. IQVIA Holdings Inc.: Company Snapshot	105
Table 43. IQVIA Holdings Inc.: Business Segmentation	106
Table 44. IQVIA Holdings Inc.: Revenue by Region, 2020, %	106
Table 45. IQVIA Holdings Inc.: Product Portfolio	107
Table 46. LSK Global Pharma Service Co., Ltd.: Company Snapshot	109
Table 47. Novotech Pty Ltd: Company Snapshot	111
Table 48. PAREXEL International Corporation: Company Snapshot	113
Table 49. PAREXEL International Corporation: Business Segmentation	114
Table 50. PAREXEL International Corporation: Revenue by Region, 2018, %	114
Table 51. PAREXEL International Corporation: Product Portfolio	115
Table 52. Pharmaceutical Product Development LLC (PPD): Company Snapshot	117
Table 53. PRA Health Sciences Inc.: Company Snapshot	119
Table 54. PRA Health Sciences Inc.: Business Segmentation	120
Table 55. PRA Health Sciences Inc.: Revenue by Region, 2018, %	120
Table 56. Quanticate Ltd: Company Snapshot	121
Table 57. Samsung Bioepis Co., Ltd.: Company Snapshot	123
Table 58. SGS SA (SGS Life Sciences): Company Snapshot	125
Table 59. SGS SA (SGS Life Sciences): Business Segmentation	126
Table 60. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %	126
Table 61. Syneos Health Inc.: Company Snapshot	128
Table 62. Syneos Health Inc.: Business Segmentation	129
Table 63. Syneos Health Inc.: Revenue by Region, 2018, %	129
Table 64. WuXi AppTec Inc.: Company Snapshot	131
Table 65.  Risk Evaluation for Investing in Asia Pacific Market, 2021-2030	134
Table 66. Critical Success Factors and Key Takeaways	137
List Of Figures:


Figure 1.  Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030	17
Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn	20
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market	25
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	30
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	31
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market	33
Figure 12. Investment Opportunity Analysis	37
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market	40
Figure 14. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue	45
Figure 15. Asia Pacific Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)	45
Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn	46
Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn	47
Figure 18. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn	48
Figure 19. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn	49
Figure 20. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn	50
Figure 21. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn	51
Figure 22. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn	52
Figure 23. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn	53
Figure 24. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue	55
Figure 25. Asia Pacific Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)	55
Figure 26. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn	56
Figure 27. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn	57
Figure 28. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn	58
Figure 29. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn	59
Figure 30. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn	60
Figure 31. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn	61
Figure 32. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn	62
Figure 33. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn	63
Figure 34. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue	65
Figure 35. Asia Pacific Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)	65
Figure 36. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn	66
Figure 37. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn	67
Figure 38. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn	68
Figure 39. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue	70
Figure 40. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	71
Figure 41.  Pharmaceutical CRO Market in Japan, 2019-2030, $ bn	73
Figure 42.  Pharmaceutical CRO Market in China, 2019-2030, $ bn	75
Figure 43.  Pharmaceutical CRO Market in Australia, 2019-2030, $ bn	77
Figure 44.  Pharmaceutical CRO Market in India, 2019-2030, $ bn	79
Figure 45.  Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn	82
Figure 46.  Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn	84
Figure 47. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period	86

Selected Key Players: 
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)